BEAM
Price
$17.83
Change
-$1.70 (-8.70%)
Updated
Apr 1, 03:57 PM (EDT)
Capitalization
2.22B
42 days until earnings call
DNLI
Price
$12.20
Change
-$1.41 (-10.37%)
Updated
Apr 1, 02:35 PM (EDT)
Capitalization
2.15B
42 days until earnings call
Ad is loading...

BEAM vs DNLI

Header iconBEAM vs DNLI Comparison
Open Charts BEAM vs DNLIBanner chart's image
Beam Therapeutics
Price$17.83
Change-$1.70 (-8.70%)
Volume$2.33K
Capitalization2.22B
Denali Therapeutics
Price$12.20
Change-$1.41 (-10.37%)
Volume$991
Capitalization2.15B
BEAM vs DNLI Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. DNLI commentary
Apr 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and DNLI is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 01, 2025
Stock price -- (BEAM: $19.53 vs. DNLI: $13.60)
Brand notoriety: BEAM and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 308% vs. DNLI: 315%
Market capitalization -- BEAM: $2.22B vs. DNLI: $2.15B
BEAM [@Biotechnology] is valued at $2.22B. DNLI’s [@Biotechnology] market capitalization is $2.15B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileDNLI’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while DNLI’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 6 bearish.
  • DNLI’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -18.66% price change this week, while DNLI (@Biotechnology) price change was -7.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.81%. For the same industry, the average monthly price growth was -13.05%, and the average quarterly price growth was -11.98%.

Reported Earning Dates

BEAM is expected to report earnings on May 13, 2025.

DNLI is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-8.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.22B) and DNLI($2.15B) have the same market capitalization . BEAM YTD gains are higher at: -21.250 vs. DNLI (-33.292). BEAM has higher annual earnings (EBITDA): -383.98M vs. DNLI (-492.89M). BEAM (851M) and DNLI (832M) have equal amount of cash in the bank . DNLI has less debt than BEAM: DNLI (48.7M) vs BEAM (161M). BEAM has higher revenues than DNLI: BEAM (63.5M) vs DNLI (0).
BEAMDNLIBEAM / DNLI
Capitalization2.22B2.15B103%
EBITDA-383.98M-492.89M78%
Gain YTD-21.250-33.29264%
P/E RatioN/AN/A-
Revenue63.5M0-
Total Cash851M832M102%
Total Debt161M48.7M331%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMDNLI
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 5 days ago
89%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 5 days ago
79%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 7 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBAKX28.66N/A
N/A
Fidelity Balanced K
APGRX18.18N/A
N/A
Yorktown Growth Institutional
MISGX11.72N/A
N/A
Meridian Small Cap Growth Investor
GTFPX28.76N/A
N/A
Goldman Sachs International Eq ESG P
THGCX23.30-0.24
-1.02%
Thornburg International Equity C

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with ARWR. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then ARWR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
-8.02%
ARWR - DNLI
55%
Loosely correlated
-7.81%
BEAM - DNLI
54%
Loosely correlated
-12.07%
RCKT - DNLI
54%
Loosely correlated
-12.12%
CRSP - DNLI
53%
Loosely correlated
-8.00%
NTLA - DNLI
52%
Loosely correlated
-11.90%
More